Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2
Open accessThe DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index; 51 of the 69 sources its claims cite were checked for support.
Abstract
While macrophage heterogeneity during metabolic dysfunction-associated steatohepatitis (MASH) has been described, the fate of these macrophages during MASH regression is poorly understood. Comparing macrophage heterogeneity during MASH progression vs regression, we identified specific macrophage subpopulations that are critical for MASH/fibrosis resolution. We elucidated the restorative pathways and gene signatures that define regression-associated macrophages and establish the importance of TREM2 + macrophages during MASH regression. Liver-resident Kupffer cells are lost during MASH and are replaced by four distinct monocyte-derived macrophage subpopulations. Trem2 is expressed in two macrophage subpopulations: i) monocyte-derived macrophages occupying the Kupffer cell niche (MoKC) and ii) lipid-associated macrophages (LAM). In regression livers, no new transcriptionally distinct macrophage subpopulation emerged. However, the relative macrophage composition changed during regression compared to MASH. While MoKC was the major macrophage subpopulation during MASH, they decreased during regression. LAM was the dominant macrophage subtype during MASH regression and maintained Trem2 expression. Both MoKC and LAM were enriched in disease-resolving pathways. Absence of TREM2 restricted the emergence of LAMs and formation of hepatic crown-like structures. TREM2 + macrophages are functionally important not only for restricting MASH-fibrosis progression but also for effective regression of inflammation and fibrosis. TREM2 + macrophages are superior collagen degraders. Lack of TREM2 + macrophages also prevented elimination of hepatic steatosis and inactivation of HSC during regression, indicating their significance in metabolic coordination with other cell types in the liver. TREM2 imparts this protective effect through multifactorial mechanisms, including improved phagocytosis, lipid handling, and collagen degradation.
Overview
CoChat Summary
## TL;DR
Using two mouse models of MASH, the paper shows that TREM2+ lipid-associated macrophages (LAMs) are the main restorative macrophage population during regression and are needed for fibrosis resolution. Loss of TREM2 impairs collagen resorption, steatosis clearance, and hepatic stellate cell inactivation.
## Key findings
- In Foz/Foz mice, switching from Western diet to chow for regression improved MASH within 4 weeks and continued through 8 weeks, but Foz::Trem2−/− mice had markedly impaired recovery: they failed to eliminate hepatic steatosis and had significantly worse fibrosis resolution.
- Fibrosis resolution was quantified as 70% at 8 weeks in Foz/Foz mice versus 30% at 8 weeks in Foz::Trem2−/− mice; the linear regression slopes were −0.087 vs −0.039, respectively.
- scRNAseq of 18 immune cell clusters identified 4 monocyte-derived macrophage populations emerging during MASH; during regression, LAMs (cluster 2) remained constant and became the major macrophage subpopulation, while MoKC shrank.
- TREM2+ macrophages were enriched for phagocytosis, anti-fibrosis, ECM degradation, and lipid/lipoprotein handling, whereas TREM2-low macrophages were enriched for inflammation, cytokine signaling, and cell death.
- Absence of TREM2 reduced GPNMB+ LAMs and hCLS in both MASH and regression, increased inflammatory macrophages, and impaired collagen degradation; in BMDMs, Trem2−/− cells were less efficient at collagen degradation than WT.
- In the second MASH model (WD + 30% fructose in drinking water), Trem2−/− mice developed more severe MASH/fibrosis, and about 60% progressed spontaneously to HCC with an average of 5 tumors/liver of average diameter 2.5 mm.
## Methods
- Two preclinical mouse models were used: Foz/Foz mice and Trem2−/− mice on a C57BL/6J background, plus Foz::Trem2−/− crosses; mice were fed Western diet or WD + 30% fructose to induce MASH, then some were switched to chow for regression.
- Regression in the Foz model was assessed at 4 and 8 weeks after WD→chow switch; a separate cohort stayed on WD for 20 weeks as a disease-control group.
- The main analyses included scRNAseq of immune cells from healthy, MASH, and regression livers; flow cytometry, immunohistochemistry, Luminex cytokine/chemokine profiling, gene expression analysis, and collagenase/collagen degradation assays. Group comparisons used ANOVA and Student’s t test.
## Limitations
- The paper states that the role of hepatic LAM/hCLS in MASH “remains unresolved” and that the mechanisms by which TREM2 modulates HSC inactivation and hepatic lipid metabolism during regression “need further investigation.”
- The paper notes that the myeloid population may need “longer time to return to homeostasis,” implying that the 8-week regression window may be too short to capture full recovery.
- The text makes evident that much of the mechanistic work is based on mouse models rather than direct human intervention studies (text-evident).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
39 Valid · 2 Not valid · 6 Not checked · 132 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“and fibrotic scars (SAM) (6)”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Abstract
What the sources say
- Supportedcites [6] P. Ramachandran, Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512– 518 (2019), 10.1038/s41586-019-1631-3. 31597160 PMC6876711 source
The Results section, “Distinct macrophage subpopulations inhabit the fibrotic niche” (page not supplied), reports that scar-associated macrophages (SAMΦ) were localized in collagen-positive scar regions and accumulated within the fibrotic niche. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“MASH is associated with the emergence of lipid-associated macrophages (LAM) that highly express Trem2 along with Cd9, Gpnmb, and Spp1 (3–5)”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Abstract
What the sources say
- Partly supportedcites [3] A. Remmerie, Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity 53, 641– 657.e614 (2020). 32888418 PMC7501731 sourceExperimental — accuracy not yet measured
The Results section, “Hepatic Lipid-Associated Macs Differentiate in MAFLD” (page unavailable), identifies hepatic LAMs in diet-induced fatty liver disease and reports increased Cd9 and Trem2 expression and Spp1 enrichment. The Discussion says LAMs appeared in later disease stages, consistent with an association with steatohepatitis. The paper does not establish high Gpnmb expression in these cells; its GPNMB flow-cytometry test gave no signal above controls. (LLM, conf=0.86)
- Partly supportedcites [4] D. A. Jaitin, Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell 178, 686– 698.e614 (2019). 31257031 PMC7068689 sourceExperimental — accuracy not yet measured
The Results section, “Lipid-associated macrophages are characterized by Trem2 expression in mice and humans” (page not provided), identifies LAMs in obese adipose tissue as expressing Trem2 and Cd9 and reports LAM-like macrophages in mouse liver under high-fat-diet conditions. The paper does not establish their emergence specifically in MASH or identify Gpnmb as part of the reported LAM signature; it mentions Spp1 as differing among macrophage subsets, not as a confirmed high-expression LAM marker. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [5] J. S. Seidman, Niche-specific reprogramming of epigenetic landscapes drives myeloid cell diversity in nonalcoholic steatohepatitis. Immunity 52, 1057– 1074.e1057 (2020). 32362324 PMC7305990 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“are equivalent to the scar-associated macrophages (SAM) in human MASH (6–8)”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Abstract
What the sources say
- Partly supportedcites [6] P. Ramachandran, Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512– 518 (2019), 10.1038/s41586-019-1631-3. 31597160 PMC6876711 sourceExperimental — accuracy not yet measured
The Results section ('Pro-fibrogenic phenotype of scar-associated macrophages'; page unavailable) reports expansion of scar-associated macrophages (SAMΦ) in patients with NASH, now termed MASH. Our copy does not identify these cells as LAMs or establish that the two populations are equivalent. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [7] T. Fabre, Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation. Sci. Immunol. 8, eadd8945 (2023). 37027478 source
- Partly supportedcites [8] C. Zwicker, A. Bujko, C. L. Scott, Hepatic macrophage responses in inflammation, a function of plasticity, heterogeneity or both? Front. Immunol. 12, 690813 (2021). 34177948 PMC8220199 sourceExperimental — accuracy not yet measured
The Murine Hepatic Macrophages section says alignment of murine LAMs and human SAMs showed significant overlap, suggesting they could be equivalent populations. It does not establish equivalence as fact, and it describes human SAMs in fibrotic or cirrhotic livers rather than specifically in human MASH. Page numbers are unavailable in the supplied copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“LAMs/SAMs increase with MASH severity (3, 10)”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Abstract
What the sources say
- Partly supportedcites [3] A. Remmerie, Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity 53, 641– 657.e614 (2020). 32888418 PMC7501731 sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says hepatic LAMs were identified only in later disease stages, correlating with worsening disease and fibrosis; the mouse model developed NASH at later time points. The Results section on hepatic LAMs (page not provided) notes overlap with scar-associated macrophages (SAMs) in fibrotic human livers, but does not show that SAMs increase with MASH severity. (LLM, conf=0.85)
- Partly supportedcites [10] S. Daemen, Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep. 34, 108626 (2021). 33440159 PMC7877246 sourceExperimental — accuracy not yet measured
In Results (‘MdMs and Aggregate Formation in the NASH’; page unavailable), LAM/C-LAM markers are absent or rare with a standard diet but abundant in steatotic livers of high-fat-diet-fed mice. The paper says some macrophages share genes associated with SAMs from human cirrhosis; it does not show that SAM numbers increase with MASH severity or establish a severity-dependent increase for both populations. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“analyses of two publicly available scRNAseq datasets (3, 9) indicate that macrophages are the major cell types that express TREM2 in the MASH livers”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Results > TREM2 in MASH.
What the sources say
- Partly supportedcites [3] A. Remmerie, Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver. Immunity 53, 641– 657.e614 (2020). 32888418 PMC7501731 sourceExperimental — accuracy not yet measured
The Results section, “Hepatic Lipid-Associated Macs Differentiate in MAFLD” (page unavailable), reports increased Trem2 expression across macrophage subsets in fatty-liver mice. It does not establish that macrophages are the major TREM2-expressing cell type across all cells in MASH livers: the study’s single-cell analysis was restricted to CD45+ immune cells. (LLM, conf=0.83)
- Partly supportedcites [9] M. Guilliams, Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185, 379– 396.e338 (2022). 35021063 PMC8809252 sourceExperimental — accuracy not yet measured
The Supplemental figures (p. 50) quantify Gpnmb and Trem2 transcripts relative to the macrophage marker Adgre1, linking Trem2 to hepatic macrophages. But the passage concerns tissue regions, not a comparison of TREM2 expression across cell types in MASH livers; it does not establish that macrophages are the major TREM2-expressing cell type there. (LLM, conf=0.78)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
111 more claims · 12 with their cited sources checked
Create a free account to see all 179 claims and every source verdict.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 23
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the majority of murine studies to date have suggested a role for LAMs/LAM-like KCs in tissue repair, contributing to dead cell and lipid clearance, thus reducing lipotoxic stress, and preventing uncontrolled inflammation (36, 108, 122–126)”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in experimental liver fibrosis in murine models, TREM2-deficient macrophages failed to acquire reparative phenotypes, showed impaired efferocytosis, and exacerbated fibrogenesis (36, 122–126).”
From Targeting macrophages in liver fibrosis (2026) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with these findings, Ganguli et al. (10) identified Mo-KCs and LAMs as the predominant macrophage populations in MASH.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While Mo-KCs predominate during active disease, LAMs become dominant during regression, maintaining TREM2 expression.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Notably, during disease regression, fibrosis resolution was associated not with the emergence of new macrophage subsets but with a shift in population dynamics.”
From Strategies to promote liver fibrosis amelioration with involvement of restorative macrophages (2026) · cites this paper as [10]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“From the 18 different immune cell clusters (SI Appendix, Fig. S3 A and B and Dataset S1), we focused our analysis on 6 monocyte/macrophage clusters (clusters 0, 1, 2, 5, and 15) (Fig. 3A).”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Results > Macrophage Heterogeneity during MASH Progression and Regression.
Reported 6 · recomputed 23
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Results > Macrophage Heterogeneity during MASH Progression and Regression.
“From the 18 different immune cell clusters (SI Appendix, Fig. S3 A and B and Dataset S1), we focused our analysis on 6 monocyte/macrophage clusters (clusters 0, 1, 2, 5, and 15) (Fig. 3A).”
§ Lipid-associated macrophages’ promotion of fibrosis resolution during MASH regression requires TREM2 > Results > Macrophage Heterogeneity during MASH Progression and Regression.
“In MASH livers the Timd4+EmKCs were depleted, as reported (3, 5, 10, 34), and were replaced by four distinct Timd4-clusters (clusters 5, 15, 1, 2) that were derived from circulating monocytes, also known as recruited macrophages (RM) (Fig. 3 A−C and SI Appendix, Fig. S3C).”
Citations
Cites
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · cited 1×
“Most of the existing knowledge regarding liver fibrosis resolution is derived from mouse models of chemical (CCl 4 or acetaminophen) - induced fibrosis and regression ( 17 – 21 ).”
Self-citationResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 4×
“Although TREM2 has been shown to be up - regulated in advanced MASH livers ( 6 , 16 ), at what stage TREM2 is induced during the disease progression and what event (such as steatosis, fibrosis, or hepatocyte death) triggers TREM2 upregulation are not clear.”
InfluentialSelective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner
Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.054 · Cited by 1,377 · cited 3×
“While some studies reported increased body and liver weight in Trem2 −/− mice on HFD or WD ( 4 , 12 , 40 ), the Winn et al. study ( 41 ) and ours did not observe such differences.”
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Mridha, A. R., Wree, A., Robertson, A. A. B., Yeh, M. M., Johnson, C. D., Van Rooyen, D. M., Haczeyni, F., Teoh, N. C.-H., Savard, C., Ioannou, G. N., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.022 · Cited by 1,110 · cited 1×
“Inflammasome activation is a hallmark of MASH livers ( 42 ), and we found that TREM2 restrains NLRP3 inflammasome activation.”
Self-citationRamachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001 · cited 3×
“While the restorative macrophages that play key roles in fibrosis resolution have been studied in the context of chemical - induced fibrosis regression (17, 20), their identity during MASH resolution is unknown.”
Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches
Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Wagner, C., Remmerie, A., Bujko, A., Martens, L., Thoné, T., Browaeys, R., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.018 · Cited by 985
Wree, A., Eguchi, A., McGeough, M. D., Pena, C. A., Johnson, C. D., Canbay, A., Hoffman, H. M., & Feldstein, A. E. (2014) · Hepatology · doi:10.1002/hep.26592 · Cited by 945 · cited 1×
“2 F ), indicating that Trem2 −/− MASH livers have enhanced NLRP3 inflammasome activation, a key activator of liver inflammation in MASH (25, 26).”
Self-citationThe role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941 · cited 1×
“Macrophages play a central role in orchestrating MASH progression and resolution ( 37 ).”
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805 · cited 1×
“Therefore, to evaluate the effective reduction in collagen levels following the dietary switch, the SR score of each regression group was normalized to the corresponding MASH SR score (at 12 wk WD just before the switch) as previously reported for CCl 4 fibrosis resolution studies ( 33 ).”
Self-citationXiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784 · cited 1×
“Although TREM2 has been shown to be up - regulated in advanced MASH livers ( 6 , 16 ), at what stage TREM2 is induced during the disease progression and what event (such as steatosis, fibrosis, or hepatocyte death) triggers TREM2 upregulation are not clear.”
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688 · cited 5×
“In both MASH models, the systemic levels of LPS and LPS binding protein (LBP) remained unaltered irrespective of the presence or absence of TREM2 (Fig.”
InfluentialThe Physiology, Pathology, and Potential Therapeutic Applications of the TREM2 Signaling Pathway
Deczkowska, A., Weiner, A., & Amit, I. (2020) · Cell · doi:10.1016/j.cell.2020.05.003 · Cited by 648
Remmerie, A., Martens, L., Thoné, T., Castoldi, A., Seurinck, R., Pavie, B., Roels, J., Vanneste, B., De Prijck, S., Vanhockerhout, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.004 · Cited by 592 · cited 1×
“However, analyses of two publicly available scRNAseq datasets (3, 9) indicate that macrophages are the major cell types that express TREM2 in the MASH livers ( SI Appendix , Fig.”
Seidman, J. S., Troutman, T. D., Sakai, M., Gola, A., Spann, N. J., Bennett, H., Bruni, C. M., Ouyang, Z., Li, R. Z., Sun, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.001 · Cited by 443 · cited 1×
“Previous studies have reported that TREM2 is expressed in recruited monocytes, liver - resident Kupffer cells, hepatic stellate cells (HSC), and endothelial cells (5, 12, 23).”
Self-citationDistinct macrophage populations direct inflammatory versus physiological changes in adipose tissue
Hill, D. A., Lim, H.-W., Kim, Y. H., Ho, W. Y., Foong, Y. H., Nelson, V. L., Nguyen, H. C. B., Chegireddy, K., Kim, J., Habertheuer, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802611115 · Cited by 415 · cited 1×
“The role of hepatic LAM and hCLS in MASH ( 10 , 35 ) as well as adipose tissue LAM and CLS during obesity ( 4 , 39 ) remains unresolved.”
Tran, S., Baba, I., Poupel, L., Dussaud, S., Moreau, M., Gélineau, A., Marcelin, G., Magréau-Davy, E., Ouhachi, M., Lesnik, P., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.003 · Cited by 400 · cited 2×
“Thus, cluster 1 represents macrophages that are similar to but distinct from the EmKCs known as monocyte - derived Kupffer cells (MoKC) ( 3 , 5 , 10 , 34 ), which occupy the EmKC niche during MASH.”
Colonna, M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00837-1 · Cited by 394
Daemen, S., Gainullina, A., Kalugotla, G., He, L., Chan, M. M., Beals, J. W., Liss, K. H., Klein, S., Feldstein, A. E., Finck, B. N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108626 · Cited by 378 · cited 6×
“TREM2 + macrophages are also classified as LAM that are found to be associated with hepatic crown - like structures (hCLS) surrounding hypertrophic lipid - laden hepatocytes (10) ( SI Appendix , Fig.”
InfluentialSelf-citationIdentification of a broadly fibrogenic macrophage subset induced by type 3 inflammation
Fabre, T., Barron, A. M. S., Christensen, S. M., Asano, S., Bound, K., Lech, M. P., Wadsworth, M. H., Chen, X., Wang, C., Wang, J., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add8945 · Cited by 355 · cited 1×
“E ), that are characteristics of SAM described in humans ( 6 , 7 ).”
Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
Fuke, N., Nagata, N., Suganuma, H., & Ota, T. (2019) · Nutrients · doi:10.3390/nu11102277 · Cited by 268
Wang, X., He, Q., Zhou, C., Xu, Y., Liu, D., Fujiwara, N., Kubota, N., Click, A., Henderson, P., Vancil, J., et al. (2023) · Immunity · doi:10.1016/j.immuni.2022.11.013 · Cited by 262 · cited 3×
“TREM2 + macrophages were shown to be efficient in efferocy-tosis and removal of damaged hepatocytes ( 15 ).”
InfluentialHou, J., Zhang, J., Cui, P., Zhou, Y., Liu, C., Wu, X., Ji, Y., Wang, S., Cheng, B., Ye, H., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135197 · Cited by 239 · cited 1×
“A recent study indicates that the absence of TREM2 changes the exosome miRNA profile that alters the macrophage–hepatocyte metabolic coordination in MAFL and sepsis ( 13 ).”
Hendrikx, T., Porsch, F., Kiss, M. G., Rajcic, D., Papac-Miličević, N., Hoebinger, C., Goederle, L., Hladik, A., Shaw, L. E., Horstmann, H., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.004 · Cited by 220
Cottam, M. A., Caslin, H. L., Winn, N. C., & Hasty, A. H. (2022) · Nature Communications · doi:10.1038/s41467-022-30646-4 · Cited by 216 · cited 1×
“A similar phenomenon was observed in adipose tissue, where adipose tissue LAMs increased during obesity, persisted after weight loss, and continued to express Trem2 ( 38 ).”
Itoh, M., Kato, H., Suganami, T., Konuma, K., Marumoto, Y., Terai, S., Sakugawa, H., Kanai, S., Hamaguchi, M., Fukaishi, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082163 · Cited by 211 · cited 2×
“The functional role of LAMs and hCLS in MASH is debated (10, 35).”
Dual Role of CCR2 in the Constitution and the Resolution of Liver Fibrosis in Mice
Mitchell, C., Couton, D., Couty, J.-P., Anson, M., Crain, A.-M., Bizet, V., Rénia, L., Pol, S., Mallet, V., & Gilgenkrantz, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080632 · Cited by 189
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
Wan, X., Xu, C., Yu, C., & Li, Y. (2016) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2016/6489012 · Cited by 174 · cited 1×
“2 F ), indicating that Trem2 −/− MASH livers have enhanced NLRP3 inflammasome activation, a key activator of liver inflammation in MASH (25, 26).”
Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis
Han, H., Ge, X., Komakula, S. S. B., Desert, R., Das, S., Song, Z., Chen, W., Athavale, D., Gaskell, H., Lantvit, D., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.228 · Cited by 155 · cited 1×
“A recent study indicates that macrophage - derived Osteopontin (a hallmark of hepatic LAM) is protective in MASH ( 11 ).”
Heterogeneity of HSCs in a Mouse Model of NASH
Rosenthal, S. B., Liu, X., Ganguly, S., Dhar, D., Pasillas, M. P., Ricciardelli, E., Li, R. Z., Troutman, T. D., Kisseleva, T., Glass, C. K., et al. (2021) · Hepatology · doi:10.1002/hep.31743 · Cited by 145
Self-citationNon-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage
Perugorria, M. J., Esparza-Baquer, A., Oakley, F., Labiano, I., Korosec, A., Jais, A., Mann, J., Tiniakos, D., Santos-Laso, A., Arbelaiz, A., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314107 · Cited by 144
Macrophage Phenotype in Liver Injury and Repair
Sun, Y. ‐., Li, X. ‐., Meng, X. ‐., Huang, C., Zhang, L., & Li, J. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12468 · Cited by 137
Huang, P., Zhang, Z., Zhang, P., Feng, J., Xie, J., Zheng, Y., Liang, X., Zhu, B., Chen, Z., Feng, S., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03713-0 · Cited by 111
Regulation of TREM expression in hepatic macrophages and endothelial cells during acute endotoxemia
Chen, L. C., Laskin, J. D., Gordon, M. K., & Laskin, D. L. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.11.004 · Cited by 103
The Multifaceted Roles of Macrophages in NAFLD Pathogenesis
Vonderlin, J., Chavakis, T., Sieweke, M., & Tacke, F. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.03.002 · Cited by 96 · cited 1×
“Although macrophages are pivotal in both the progression and regression of MASH ( 32 ), the characteristics of restorative macrophages that orchestrate fibrosis resolution during MASH regression have not been identified.”
Coelho, I., Duarte, N., Barros, A., Macedo, M. P., & Penha-Gonçalves, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.616044 · Cited by 70 · cited 3×
“Most of the existing knowledge regarding liver fibrosis resolution is derived from mouse models of chemical (CCl 4 or acetaminophen) - induced fibrosis and regression ( 17 – 21 ).”
Wang, Y., Cao, C., Zhu, Y., Fan, H., Liu, Q., Liu, Y., Chen, K., Wu, Y., Liang, S., Li, M., et al. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05193-x · Cited by 69
Beneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages
Sharif, O., Brunner, J. S., Korosec, A., Martins, R., Jais, A., Snijder, B., Vogel, A., Caldera, M., Hladik, A., Lakovits, K., et al. (2021) · Diabetes · doi:10.2337/db20-0572 · Cited by 58 · cited 2×
“While some studies reported increased body and liver weight in Trem2 −/− mice on HFD or WD ( 4 , 12 , 40 ), the Winn et al. study ( 41 ) and ours did not observe such differences.”
Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet
Ganguly, S., Muench, G. A., Shang, L., Rosenthal, S. B., Rahman, G., Wang, R., Wang, Y., Kwon, H. C., Diomino, A. M., Kisseleva, T., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.05.010 · Cited by 50
Self-citationHepatic Macrophage Responses in Inflammation, a Function of Plasticity, Heterogeneity or Both?
Zwicker, C., Bujko, A., & Scott, C. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.690813 · Cited by 41 · cited 1×
“TREM2 + hepatic LAMs are transcriptionally similar to adipose tissue LAMs, emerge during MASH, and are recruited to hCLS 8 .”
Qu, W., Wang, Y., Wu, Y., Liu, Y., Chen, K., Liu, X., Zou, Z., Huang, X., & Wu, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01121 · Cited by 40 · cited 1×
“Indeed, consistent with our in vivo data, studies with WT and Trem2 −/− BMDMs have reported an inherent hyperinflammatory phenotype of Trem2 −/− BMDM in response to LPS (27) as well as an increased NLRP3 activation in the context of bacterial infection and neuro - inflammation (28–30).”
Exon 2‐mediated deletion of Trem2 does not worsen metabolic function in diet‐induced obese mice
Winn, N. C., Wolf, E. M., Garcia, J. N., & Hasty, A. H. (2022) · The Journal of Physiology · doi:10.1113/jp283684 · Cited by 30 · cited 3×
“While some studies reported increased body and liver weight in Trem2 −/− mice on HFD or WD ( 4 , 12 , 40 ), the Winn et al. study ( 41 ) and ours did not observe such differences.”
Research works printed but not linked: 1
- S. Ganguly Lipid Associated Macrophages’ Promotion of Fibrosis Resolution during MASH regression requires TREM2. GEO. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261829. Deposited 18 March 2024.
Cited by
MASH: the nexus of metabolism, inflammation, and fibrosis
Steinberg, G. R., Carpentier, A. C., & Wang, D. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186420 · Cited by 156
Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair
De Ponti, F. F., Bujko, A., Liu, Z., Collins, P. J., Schuermans, S., Maueroder, C., Amstelveen, S., Thoné, T., Martens, L., McKendrick, J. G., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.01.002 · Cited by 94
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
“Moreover, the subpopulation of TREM2-expressing lipid-associated macrophages is important for the efferocytosis of dying hepatocytes and repair [267, 268].”
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81
“A recent study indicated that macrophage heterogeneity in livers undergoing MASH regression closely mirrors that of active MASH [25].”
InfluentialSelf-citationTREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57024-0 · Cited by 74
Metadata
- Authors
- Ganguly, S., Rosenthal, S. B., Ishizuka, K., Troutman, T. D., Rohm, T. V., Khader, N., Aleman-Muench, G., Sano, Y., Archilei, S., Soroosh, P., Olefsky, J. M., Feldstein, A. E., Kisseleva, T., Loomba, R., Glass, C. K., Brenner, D. A., & Dhar, D.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- University of California San Diego (US)
- Cincinnati Children's Hospital Medical Center (US)
- Cardiovascular and Metabolism discovery, Immunometabolism, Janssen Research & Development, La Jolla, CA 92121
- Corresponding author
- Glass, Christopher K.
- Brenner, David A.
- Dhar, Debanjan
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2024-08-22
- Volume
- 121
- Issue
- 35
- Pages
- e2405746121-e2405746121
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC11363294
- OpenAlex
- W4401753386
- Cited by
- 145
- References
- 44
- Citations by year
- 2026: 80 · 2025: 62 · 2024: 3
- FWCI
- 37.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK137061 R01DK133930DK091183)
- HHS | NIH | National Heart, Lung, and Blood Institute (HL147835)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- TREM2, nonalcoholic steatohepatitis, lipid-associated macrophages, Kupffer cells, monocyte-derived macrophages, macrophage heterogeneity, crown-like structures, collagen degradation, hepatic steatosis, phagocytosis, lipid handling, liver inflammation
- MeSH terms
- Animals, Fatty Liver, Kupffer Cells, Lipids, Liver, Liver Cirrhosis, Macrophages, Male, Membrane Glycoproteins, Mice, Inbred C57BL, Receptors, Immunologic, Mice, Knockout, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.